Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Terminated
×
loncastuximab tesirine
×
Clear all
Filters
3
NCT05144009
2025-01-30
LOTIS-9
ADC Therapeutics S.A.
Phase 2
Terminated
41 enrolled
19 charts
NCT04699461
2023-10-23
LOTIS-6
ADC Therapeutics S.A.
Phase 2
Terminated
6 enrolled
9 charts